Basic Sciencelow evidence
Synergistic senolytic-regenerative therapy significantly extends healthspan and lifespan.
Journal of translational medicine·June 8, 2026·PMID 42260530
Why it mattersFor clinicians in regenerative medicine and longevity, this study provides mechanistic evidence that senescent cell burden limits MSC efficacy, supporting a rationale for combining senolytics with cell therapies to improve tissue repair and potentially modify biological aging.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled